In 2024, Medicare will, for the first time, have authority under the Inflation Reduction Act passed in 2022 to negotiate drug prices with pharmaceutical manufacturers. On August 29, the Centers for Medicare and Medicaid...more
9/5/2023
/ Centers for Medicare & Medicaid Services (CMS) ,
Constitutional Challenges ,
Drug Pricing ,
Eighth Amendment ,
Fifth Amendment ,
First Amendment ,
Free Speech ,
Health Insurance ,
Healthcare ,
Healthcare Reform ,
Inflation Reduction Act (IRA) ,
Manufacturers ,
Medicare ,
Medicare Part D ,
Pharmaceutical Industry ,
Prescription Drugs ,
Regulatory Takings
Proposed Protections for Patient Data Related to Reproductive Care -
On April 12, 2023, the Office for Civil Rights (OCR) at the U.S. Department of Health & Human Services (HHS) proposed a new rule to strengthen HIPAA...more
5/16/2023
/ Abortion ,
Centers for Medicare & Medicaid Services (CMS) ,
Children's Health Insurance Program (CHIP) ,
Data Privacy ,
Department of Health and Human Services (HHS) ,
Enforcement Guidance ,
Health Care Providers ,
Health Insurance ,
Health Insurance Portability and Accountability Act (HIPAA) ,
Healthcare ,
Managed Care Contracts ,
Medicaid ,
OCR ,
OIG ,
PHI ,
Reproductive Healthcare Issues ,
Women's Rights